Crypto treasury companies like SBET aren't driving crypto prices because they redistribute existing holdings to retail at ...

Investing.com - Goldman Sachs (NYSE: GS) has resumed coverage on CG Oncology (NASDAQ: CGON) with a Buy rating and a price target of $40.00 on Thursday. The stock, currently trading at $27.04, appears ...

Additionally, TD Cowen has started coverage on Amylyx with a Buy rating, expressing optimism for avexitide, another key asset in Amylyx’s portfolio, which is being developed for post-bariatric ...

Analyst Ratings Published 10/07/2025, 12:16 0 Halozyme stock resumes coverage at Goldman Sachs with Neutral rating HALO 1.40% ...

Investing.com - Goldman Sachs (NYSE: GS) has resumed coverage of Halozyme Therapeutics (NASDAQ: HALO) with a Neutral rating and a $55.00 price target. The company, which has achieved a perfect ...

Glassnode lead analyst James Check said in an X post on Friday that the “Bitcoin treasury strategy has a far shorter lifespan than most expect.” ...

Analyst Ratings Published 02-07-2025, 11:28 am 0 Citi resumes WiseTech Global stock coverage with Buy rating on Cargowise potential WTC 0.00% ...

Analyst Ratings Published 07/01/2025, 07:17 AM 0 Raymond James resumes coverage on Black Diamond stock with Outperform rating BDTX 0.00% ...